Atlas Trials

Navy General Hospital, Beijing

36 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Navy General Hospital, Beijing

RecordFirmDate
Burden-Evaluated Atrial Fibrillation Progession and ThromboEmbolim Study BEAT-AF TE Study (NCT07497906)Navy General Hospital, Beijing2026-04-01
Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism (NCT06382038)Navy General Hospital, Beijing2025-10-08
G-Pola-GemOx in Refractory/Relapsed Aggressive B-Cell Lymphoma (NCT07184788)Navy General Hospital, Beijing2025-10-01
G-Pola-ZLP in Diffuse Large B-Cell Lymphoma (NCT06665217)Navy General Hospital, Beijing2025-09-24
Study on Cardiac Output Evaluation Based on Wearable Monitoring Data (NCT06938893)Navy General Hospital, Beijing2025-04-20
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management (NCT06350344)Navy General Hospital, Beijing2024-11-01
Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas (NCT06176027)Navy General Hospital, Beijing2024-10-01
CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML (NCT06470841)Navy General Hospital, Beijing2024-09-20
VA as Maintenance Therapy Post Allo-HSCT in MDS and AML (NCT06598384)Navy General Hospital, Beijing2024-09-01
Smart Technology Facilitated Venous Thromboembolism Prophylaxis Based on Bundled Evidence-based Prevention Strategies (NCT06353373)Navy General Hospital, Beijing2024-09-01
Zanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL (NCT06503263)Navy General Hospital, Beijing2024-08-30
Smart Technology Facilitated Patient-centered Venous Thromboembolism Management (NCT06350331)Navy General Hospital, Beijing2024-08-17
Effect of Aerobic Interval Training on Atrial Fibrillation Burden (NCT06491329)Navy General Hospital, Beijing2024-08-15
Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma (NCT06190067)Navy General Hospital, Beijing2023-10-30
Maternal Oxygen Administration for Fetal Distress II (NCT03764696)Navy General Hospital, Beijing2021-01-01
WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease (NCT04551456)Navy General Hospital, Beijing2020-11-30
WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction (NCT04551443)Navy General Hospital, Beijing2020-11-01
Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (NCT02368587)Navy General Hospital, Beijing2020-01-01
CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia (NCT04157569)Navy General Hospital, Beijing2019-11-05

Track Navy General Hospital, Beijing automatically

Every clearance here is in the API, with alerts when new ones post.